DLD Asset Management »

Cidara Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $26M 119k 220.89

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Stride Note 1.125% 9/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Progress Software Corp Note 1.000% 4/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Advanced Energy Inds Note 2.500% 9/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Cidara Therapeutics Com New Call Option (CDTX)

View all positions for DLD Asset Management

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BVF
BlackRock
UBS Group
Darwin Global Management
Paradigm Biocapital Advisors
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics